Mechanism by which glucose stimulates the passive absorption of small solutes by the human jejunum in vivo.

K. D. Fine,C. S. Santa Ana,J. Porter,J. Fordtran

DOI: https://doi.org/10.1016/0016-5085(94)90163-5

IF: 29.4

1994-08-01

Gastroenterology

Abstract:

What problem does this paper attempt to address?

Progress in innate immunity signaling molecule STING

SHEN Guodong,CHEN Jianzhong

DOI: https://doi.org/10.13431/j.cnki.immunol.j.20130134

2013-01-01

Abstract:As a key signaling molecule in regulating the expression of type 1 interferon,STING(stimulator of interferon genes) play an important role in anti-infection innate immunity.It’s reported that STING participates in virus-or bacteria-derived dsDNA or RNA stimulated innate immunity signaling pathway by recruiting TBK1 and activating IRF3 to induce the production of type 1 interferon.This paper summarizes the recent advancement in exploring the biological function of STING.
A Novel Transcript Isoform of STING That Sequesters Cgamp and Dominantly Inhibits Innate Nucleic Acid Sensing

Pei-Hui Wang,Sin-Yee Fung,Wei-Wei Gao,Jian-Jun Deng,Yun Cheng,Vidyanath Chaudhary,Kit-San Yuen,Ting-Hin Ho,Ching-Ping Chan,Yan Zhang,Kin-Hang Kok,Wanling Yang,Chi-Ping Chan,Dong-Yan Jin

DOI: https://doi.org/10.1093/nar/gky186

IF: 14.9

2018-01-01

Nucleic Acids Research

Abstract:STING is a core adaptor in innate nucleic acid sensing in mammalian cells, on which different sensing pathways converge to induce type I interferon (IFN) production. Particularly, STING is activated by 2'3'-cGAMP, a cyclic dinucleotide containing mixed phosphodiester linkages and produced by cytoplasmic DNA sensor cGAS. Here, we reported on a novel transcript isoform of STING designated STING-beta that dominantly inhibits innate nucleic acid sensing. STING-beta without transmembrane domains was widely expressed at low levels in various human tissues and viral induction of STING-beta correlated inversely with IFN-beta production. The expression of STING-beta declined in patients with lupus, in which type I IFNs are commonly overproduced. STING-beta suppressed the induction of IFNs, IFN-stimulated genes and other cytokines by various immunostimulatory agents including cyclic dinucleotides, DNA, RNA and viruses, whereas depletion of STING-beta showed the opposite effect. STING-beta interacted with STING-alpha and antagonized its antiviral function. STING-beta also interacted with TBK1 and prevented it from binding with STING-alpha, TRIF or other transducers. In addition, STING-beta bound to 2'3'-cGAMP and impeded its binding with and activation of STING-alpha, leading to suppression of IFN-beta production. Taken together, STING-beta sequesters 2'3'-cGAMP second messenger and other transducer molecules to inhibit innate nucleic acid sensing dominantly.
STAM transports STING oligomers into extracellular vesicles, down‐regulating the innate immune response

Jiaqi Liang,Hang Yin

DOI: https://doi.org/10.1002/jev2.12316

2023-03-24

Journal of Extracellular Vesicles

Abstract:Stimulator of interferon genes (STING) mediates the innate immune response against damaged endogenous double‐strand DNA and exogenous virus infection. The location of STING is critical to the accurate control of defence signalling pathways. Recently, the effects of extracellular vesicles (EVs) in the regulation of innate immune signalling have been reported. Nevertheless, the particular roles played by STING in EVs and the related mechanisms have remained largely unknown. Herein, we report that when STING was activated in cells, EVs derived from these cells carried STING oligomers. Signal transducing adapter molecule 1 (STAM) was found to be a STING transporter that directly interacted with STING and facilitated STING transport into EVs. Importantly, the translocation of STING into EVs was a mechanism by which STING was degraded, suppressing the innate immune response. In summary, we elucidated the mechanism and function of the translocation of STING into EVs, adding to the understanding of STING activity regulation.

cell biology
2024 Lasker Award Recipient Zhijian Chen elucidates how DNA stimulates immunity

Amy B. Heimberger

DOI: https://doi.org/10.1172/jci186104

IF: 19.456

2024-09-19

Journal of Clinical Investigation

Abstract:Cytoplasmic DNA triggers a danger signal response that has evolved to detect and eradicate infectious organisms. This year's Albert Lasker Basic Medical Research Award to Dr. Zhijian "James" Chen, Professor of Molecular Biology at UT Southwestern Medical Center, recognizes his contributions to determining the mechanism of how DNA is detected and the connection to the downstream signaling cascade that is essential for initiating an immune response. The field had established that DNA triggers proinflammatory IFN responses through the stimulator of IFN genes (STING) pathway ( 1 ) and its phosphorylation of IFN regulatory factor 3 (IRF3) — the transducer of IFN gene transcription ( 2 ). Prior studies showed that the multipass transmembrane STING protein functions as a direct innate immune sensor of bacterial elaborated cyclic diguanylate monophosphate (c-di-GMP) and cyclic diadenylate monophosphate (c-di-AMP) ( 3 ). Several DNA-sensing pattern-recognition receptors, including AIM2-related protein, IFI16, and DDX41, had previously been linked to STING activation. However, it was the Chen laboratory that discovered that the nucleotidyl transferase cyclic GMP-AMP synthase (cGAS) produces a second-messenger cyclic GMP-AMP (cGAMP) that binds to STING as the principal pathway inducing IFN (Figure 1) ( 4 , 5 ). Using a combination of mass spectrometry and protein purification strategies, cGAS was identified, and it was shown to bind to DNA and catalyze the synthesis ,of cGAMP from ATP and GTP. cGAMP binds to STING with high affinity, causing extensive ligand-induced conformational changes ( 6 ). cGAS/STING signaling and therapeutic targeting. ( A ) Activation of the cGAS/STING pathway can be triggered either through the importation of cGAMP or the presence of double-stranded DNA (dsDNA). Activated cyclic GMP-AMP synthase (cGAS) uses ATP and GTP to catalyze the formation of cGAMP that binds to STING localized on the ER membrane. STING then recruits TBK1, which activates/phosphorylates IRF3 and NF-κB, which translocates to the nucleus, thereby inducing the transcriptional activation of proinflammatory interferon responses. ( B ) A variety of therapeutics are being evaluated in clinical trials, such as cyclic dinucleotides or STING agonists that can trigger the activation of cGAS/STING pathway. The STING signal is terminated (denoted by the X) when activated STING in the ER-Golgi compartment binds to LC3 on the autophagy membrane, leading to the degradation of STING and the associated cytoplasmic DNA in the autolysosome. Excess intracellular cGAMP is transported out of the cell and hydrolyzed by ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) to yield AMP and GMP. ENPP1 inhibitors maintain proinflammatory cGAMP concentrations. ERGIC; endoplasmic-reticulum-Golgi intermediate compartment.

medicine, research & experimental
Regulating STING in health and disease

Yang Li,Heather L Wilson,Endre Kiss-Toth

DOI: https://doi.org/10.1186/s12950-017-0159-2

2017-06-07

Abstract:The presence of cytosolic double-stranded DNA molecules can trigger multiple innate immune signalling pathways which converge on the activation of an ER-resident innate immune adaptor named "STimulator of INterferon Genes (STING)". STING has been found to mediate type I interferon response downstream of cyclic dinucleotides and a number of DNA and RNA inducing signalling pathway. In addition to its physiological function, a rapidly increasing body of literature highlights the role for STING in human disease where variants of the STING proteins, as well as dysregulated STING signalling, have been implicated in a number of inflammatory diseases. This review will summarise the recent structural and functional findings of STING, and discuss how STING research has promoted the development of novel therapeutic approaches and experimental tools to improve treatment of tumour and autoimmune diseases.
Viral DNA Binding to NLRC3, an Inhibitory Nucleic Acid Sensor, Unleashes STING, a Cyclic Dinucleotide Receptor That Activates Type I Interferon.

Xin Li,Meng Deng,Alex S. Petrucelli,Cheng Zhu,Jinyao Mo,Lu Zhang,Jason W. Tam,Pablo Ariel,Baoyu Zhao,Song Zhang,Hengming Ke,Pingwei Li,Nikolay Dokholyan,Joseph A. Duncan,Jenny P-Y Ting

DOI: https://doi.org/10.1016/j.immuni.2019.02.009

2019-01-01

Abstract:Immune suppression is a crucial component of immunoregulation and a subgroup of nucleotide-binding domain (NBD), leucine-rich repeat (LRR)-containing proteins (NLRs) attenuate innate immunity. How this inhibitory function is controlled is unknown. A key question is whether microbial ligands can regulate this inhibition. NLRC3 is a negative regulator that attenuates type I interferon (IFN-I) response by sequestering and attenuating stimulator of interferon genes (STING) activation. Here, we report that NLRC3 binds viral DNA and other nucleic acids through its LRR domain. DNA binding to NLRC3 increases its ATPase activity, and ATP-binding by NLRC3 diminishes its interaction with STING, thus licensing an IFN-I response. This work uncovers a mechanism wherein viral nucleic acid binding releases an inhibitory innate receptor from its target.
STING-mediated DNA sensing in cancer immunotherapy

Xiang Zhou,Zhengfan Jiang

DOI: https://doi.org/10.1007/s11427-016-9066-0

2017-01-01

Abstract:While STING (STimulator of INterferon Genes) has been shown to be essential for cytosolic DNA-triggered innate immune activation, accumulated evidence obtained from various studies suggested that an intrinsic relevance of STING-associated signaling in tumorigenesis can be observed. Also, several clinical trials using immunostimulatory adjuvants, particularly agonistic as well as non-agonistic ligands for STING, have revealed their therapeutic potential not only as vaccine adjuvants but also as anti-tumor agents. However, cases have also been reported where the involvement of STING shows a protective role in tumor growth. Here we summarize recent findings that have pointed towards the STING pathway as an innate immune sensing mechanism driving type I interferon production in the tumor context. Better understanding of this pathway can guide further development of novel immunotherapeutic strategies in the treatment of cancer.
Advances in the Prerequisite and Consequence of STING Downstream Signalosomes

Xinliang Lu,Xiaobing Li,Lili Li,Chuanhui Han,Sirui Li

DOI: https://doi.org/10.1515/mr-2024-0016

2024-01-01

Medical Review

Abstract:The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is an evolving DNA-sensing mechanism involved in innate immunity and pathogen defense that has been optimized while remaining conserved. Aside from recognizing pathogens through conserved motifs, these receptors also detect aberrant or misplaced self-molecules as possible signs of perturbed homeostasis. Upon binding external or self-derived DNA, a mobile secondary messenger 2′3′-cyclic GMP-AMP (cGAMP) is produced by cGAS and in turn activates its adapter STING in the endoplasmic reticulum (ER). Resting-state or activated STING protein is finely restricted by multiple degradation machineries. The post-translational changes of the STING protein, along with the regulatory machinery of the secret routes, limit the onset, strength and sustention of STING signal. STING experiences a conformational shift and relocates with TBK1 from the ER to perinuclear vesicles containing transcription factors, provoking the transcription activity of IRF3/IFN-I and NF-κB pathways, as well as to initiate a number of cellular processes that have been shown to alter the immune landscape in cancer, such as autophagy, NLRP3 inflammasome, ER stress, and cell death. STING signal thus serves as a potent activator for immune mobilization yet also triggers immune-mediated pathology in tissues. Recent advances have established the vital role of STING in immune surveillance as well as tumorigenic process. This review provides an overview of the disparate outcomes of cancer attributed to the actions of pleiotropic and coordinated STING downstream signalosomes, along with the underlying mechanisms of STING function in pathologies, providing therapeutic implications for new approaches in hunt for the next generation of cancer immunotherapy base on STING.
Cgas-Sting: the Novel Mechanism of Cytosolic DNA Sensing Pathways

Ding Liang,Ni Yan-Hong,Hu Qin-Gang,Hou Ya-Yi

DOI: https://doi.org/10.3724/sp.j.1206.2013.00497

2014-01-01

Abstract:The dangerous signature came from unintegrated DNA or episome in cytoplasm could be detected by innate immunity, but how it works is unclear. Recently, more than 10 DNA sensors have been found to connect with the DNA sensing and immune defense. The cytosolic DNA induces the type I interferon and other cytokines depended on the stimulator of interferon genes, namely STING (also known as ERIS, MITA, MPYS, and TMEM173), which functions as a key adaptor protein in the DNA sensing pathways. Surprisingly, some investigators identified a novel nucleotidyl transferase, cGAS, which produces an endogenous second-messenger cGAMP to activate STING in the cytoplasm of mammalian cells. However, how DNA activates STING to induce protective immune responses against virus, protozoa and bacteria need to be explored further. In this review, we discuss the recent research progress regarding the DNA sensing by cGAS and the mechanisms involved in activation of STING and subsequently immune responses.
Engineering the Immune Adaptor Protein STING as a Biologic

Xin Sun,Yun Ni,Yanpu He,Mengdi Yang,Tetsuo Tani,Shunsuke Kitajima,David A. Barbie,Jiahe Li

DOI: https://doi.org/10.1101/2021.02.18.431824

2021-02-18

Abstract:ABSTRACT Activation of the stimulator of interferon genes (STING) pathway through cyclic dinucleotides (CDNs) has been explored extensively as potent vaccine adjuvants against infectious diseases as well as to increase tumor immunogenicity towards cancer immunotherapy in solid tumors. Over the last decade, a myriad of synthetic vehicles, including liposomes, polymers, and other nanoparticle platforms, have been developed to improve the bioavailability and therapeutic efficacy of STING agonists in preclinical mouse models. In comparison to synthetic materials, protein-based carriers represent an attractive delivery platform owing to their biocompatibility, amenability to genetic engineering, and intrinsic capacity to form well-defined structures. In the present work, we have engineered the immune adaptor STING as a protein-based delivery system for efficient encapsulation and intracellular delivery of CDNs. Through genetic fusion with a protein transduction domain, the recombinant STING can spontaneously penetrate cells to markedly enhance the delivery of CDNs in a mouse vaccination model and a syngeneic mouse melanoma model. Moreover, motivated by recent findings that certain tumor cells can evade immune surveillance via loss of STING expression, we further unveiled that our STING platform can serve as a functional vehicle to restore the STING signaling in a panel of lung and melanoma cell lines with impaired STING expression. Taken together, our STING-based protein delivery platform may offer a unique direction towards targeting STING-silenced tumors as well as augmenting the efficacy of STING-based vaccine adjuvants.
STING-dependent translation inhibition restricts RNA virus replication

Kate M. Franz,William J. Neidermyer,Yee-Joo Tan,Sean P. J. Whelan,Jonathan C. Kagan

DOI: https://doi.org/10.1073/pnas.1716937115

IF: 11.1

2018-02-12

Proceedings of the National Academy of Sciences

Abstract:Significance In mammalian cells, a protein called STING (stimulator of IFN genes) is typically viewed as a factor dedicated to defense strategies induced by DNA viruses. The antiviral activities of STING are linked to its ability to induce the expression of genes that combat viral replication cycles. In our study, we have discovered a transcription-independent function for STING in the restriction of viruses that contain RNA genomes. We found that cells lacking STING are sensitive to RNA virus infections and that during these infections, STING inhibits the translation machinery to prevent viral protein synthesis. This study therefore establishes that STING has dual functions in host defense, regulating antiviral gene expression or interfering with translation, to restrict replication of distinct classes of viruses.

multidisciplinary sciences
STING Negatively Regulates Double-Stranded DNA-Activated JAK1-STAT1 Signaling via SHP-1/2 in B Cells.

Guanjun Dong,Ming You,Liang Ding,Hongye Fan,Fei Liu,Deshan Ren,Yayi Hou

DOI: https://doi.org/10.14348/molcells.2015.2359

2015-01-01

Molecules and Cells

Abstract:Recognition of cytosolic DNA initiates a series of innate immune responses by inducing IFN-I production and subsequent triggering JAK1-STAT1 signaling which plays critical roles in the pathogenesis of infection, inflammation and autoimmune diseases through promoting B cell activation and antibody responses. The stimulator of interferon genes protein (STING) has been demonstrated to be a critical hub of type I IFN induction in cytosolic DNA-sensing pathways. However, it still remains unknown whether cytosolic DNA can directly activate the JAK1-STAT1 signaling or not. And the role of STING is also unclear in this response. In the present study, we found that dsDNA directly triggered the JAK1-STAT1 signaling by inducing phosphorylation of the Lyn kinase. Moreover, this response is not dependent on type I IFN receptors. Interestingly, STING could inhibit dsDNA-triggered activation of JAK1-STAT1 signaling by inducing SHP-1 and SHP-2 phosphorylation. In addition, compared with normal B cells, the expression of STING was significantly lower and the phosphorylation level of JAK1 was significantly higher in B cells from MRL/lpr lupus-prone mice, highlighting the close association between STING low-expression and JAK1-STAT1 signaling activation in B cells in autoimmune diseases. Our data provide a molecular insight into the novel role of STING in dsDNA-mediated inflammatory disorders.
DNA sensing via STING regulates autoimmunity and tumor immunity. (IRM5P.648)

Eslam Mohamed,Henrique Lemos,Lei Huang,Rong Ou,Gabriella Pacholczyk,Yoshihrio Hayakawa,David Munn,Andrew Mellor

DOI: https://doi.org/10.4049/jimmunol.194.supp.59.13

2015-05-01

The Journal of Immunology

Abstract:Abstract The Stimulator of Interferon Genes (STING) is activated by cytosolic DNA sensors such as cyclic GMP-AMP Synthase (cGAS) to induce interferon type I (IFN-I). Dendritic cells (DCs) that engulf dying tumor cells incite anti-tumor T cell immunity by sensing tumor cell DNA to activate STING/IFN-I signaling. Paradoxically, we find that DNA sensing to activate STING/IFN-I signaling induces DCs to express indoleamine 2, 3 dioxygenase (IDO), which activates regulatory T cells (Tregs). Thus treatment with DNA nanoparticles (DNPs) or cyclic dinucleotides (CDNs) to activate STING attenuated Experimental Autoimmune Encephalomyelitis (EAE), arthritis, and therapeutic responses were dependent on STING/IFN-I signaling to induce IDO. DNP and CDN treatments were also effective in slowing Type I Diabetes (T1D) progression in susceptible female Non-Obese Diabetic (NOD) mice. STING ablation also abolished IDO-dependent regulatory responses to apoptotic cells, suggesting that DNA from dying cells is sensed to activate the STING/IFN-I pathway and induce IDO to suppress autoimmunity. Moreover, cGAS and STING ablation abolished the ability of Lewis Lung carcinoma (LLC) tumor cells to induce local IDO, which suppresses anti-tumor immunity. These findings support the hypothesis that DNA from dying cells is sensed to activate STING/IFN-I in regulatory DCs that suppress T cell immunity and autoimmunity at sites of chronic inflammation associated with autoimmunity and tumor growth.

immunology
Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy

Zili Zhang,Haifeng Zhou,Xiaohu Ouyang,Yalan Dong,Alexey Sarapultsev,Shanshan Luo,Desheng Hu

DOI: https://doi.org/10.1038/s41392-022-01252-z

IF: 39.3

2022-12-23

Signal Transduction and Targeted Therapy

Abstract:Since the discovery of Stimulator of Interferon Genes (STING) as an important pivot for cytosolic DNA sensation and interferon (IFN) induction, intensive efforts have been endeavored to clarify the molecular mechanism of its activation, its physiological function as a ubiquitously expressed protein, and to explore its potential as a therapeutic target in a wide range of immune-related diseases. With its orthodox ligand 2'3'-cyclic GMP–AMP (2'3'-cGAMP) and the upstream sensor 2'3'-cGAMP synthase (cGAS) to be found, STING acquires its central functionality in the best-studied signaling cascade, namely the cGAS–STING–IFN pathway. However, recently updated research through structural research, genetic screening, and biochemical assay greatly extends the current knowledge of STING biology. A second ligand pocket was recently discovered in the transmembrane domain for a synthetic agonist. On its downstream outputs, accumulating studies sketch primordial and multifaceted roles of STING beyond its cytokine-inducing function, such as autophagy, cell death, metabolic modulation, endoplasmic reticulum (ER) stress, and RNA virus restriction. Furthermore, with the expansion of the STING interactome, the details of STING trafficking also get clearer. After retrospecting the brief history of viral interference and the milestone events since the discovery of STING, we present a vivid panorama of STING biology taking into account the details of the biochemical assay and structural information, especially its versatile outputs and functions beyond IFN induction. We also summarize the roles of STING in the pathogenesis of various diseases and highlight the development of small-molecular compounds targeting STING for disease treatment in combination with the latest research. Finally, we discuss the open questions imperative to answer.

biochemistry & molecular biology,cell biology
An updated patent review of stimulator of interferon genes agonists (2021 – present)

Guo-Feng Xin,Nan-Nan Chen,Lin-Lin Li,Xue-Chun Liu,Chun-Chen Che,Bei-Duo Wu,Qi-Dong You,Xiao-Li Xu

DOI: https://doi.org/10.1080/13543776.2024.2365409

2024-06-15

Expert Opinion on Therapeutic Patents

Abstract:Introduction Stimulator of Interferon Genes (STING) is an innate immune sensor. Activation of STING triggers a downstream response that results in the expression of proinflammatory cytokines (TNF-α, IL-1β) via nuclear factor kappa-B (NF-κB) or the expression of type I interferons (IFNs) via an interferon regulatory factor 3 (IRF3). IFNs can eventually result in promotion of the adaptive immune response including activation of tumor-specific CD8 + T cells to abolish the tumor. Consequently, activation of STING has been considered as a potential strategy for cancer treatment.

pharmacology & pharmacy,chemistry, medicinal
The STING Phase-Separator Suppresses Innate Immune Signalling.

Xiaoyu Yu,Liyuan Zhang,Jingxiang Shen,Yanfang Zhai,Qifei Jiang,Mengran Yi,Xiaobing Deng,Ziran Ruan,Run Fang,Zhaolong Chen,Xiaohan Ning,Zhengfan Jiang

DOI: https://doi.org/10.1038/s41556-021-00659-0

IF: 21.3

2021-01-01

Nature Cell Biology

Abstract:Biomolecular condensates (biocondensates) formed via liquid–liquid phase-separation of soluble proteins have been studied extensively. However, neither the phase-separation of endoplasmic reticulum (ER) transmembrane protein nor a biocondensate with organized membranous structures has been reported. Here, we have discovered a spherical ER membranous biocondensate with puzzle-like structures caused by condensation of the ER-resident stimulator of interferon genes (STING) in DNA virus-infected or 2′3′-cGAMP (cyclic GMP-AMP)-treated cells, which required STING transmembrane domains, an intrinsically disordered region (IDR) and a dimerization domain. Intracellular 2′3′-cGAMP concentrations determined STING translocation or condensation. STING biocondensates constrained STING and TBK1 (TANK binding protein 1) to prevent innate immunity from overactivation, presumably acting like a ‘STING-TBK1-cGAMP sponge’. Cells expressing STING-E 336 G/E 337 G showed notably enhanced innate immune responses due to impaired STING condensation after viral infection at later stages. Microtubule inhibitors impeded the STING condensate gel-like transition and augmented type I-interferon production in DNA virus-infected cells. This membranous biocondensate was therefore named the STING phase-separator.
Abstract A116: Lipid Control of DNA-stimulated Innate Immunity

Xiaojun Tan,Conggang Zhang,Zhijian J. Chen

DOI: https://doi.org/10.1158/2326-6074.cricimteatiaacr18-a116

IF: 10.1

2019-01-01

Cancer Immunology Research

Abstract:Abstract Type I interferon (IFN) plays essential roles in both spontaneous and iatrogenic tumor immunogenicity. Tumor-derived DNA is recognized by 2’,3’-cyclic GMP-AMP (cGAMP) synthase (cGAS) that is important in tumor immunogenicity. Upon DNA binding, cGAS produces the endogenous second messenger cGAMP that binds to and activates stimulator of IFN genes (STING), a signaling adaptor. cGAMP binding triggers STING trafficking from the endoplasmic reticulum (ER) to perinuclear compartments, with simultaneous activation of serine/threonine-protein kinase TBK1 that in turn phosphorylates the transcription factor IRF3, leading to upregulation of type I interferons. However, where and how TBK1 is activated by STING upon cGAMP stimulation is unclear. Our study focuses on the regulation of cGAMP-stimulated STING trafficking and activation by lipid messengers with essential roles in subcellular protein/membrane trafficking and signaling. Through in vitro signaling reconstitution, we identified a cellular lipid as an essential factor of STING signaling. We found both STING and TBK1 were lipid effectors. Lipid binding not only promotes STING trafficking but also stimulates TBK1 activation. These results reveal a new component of the STING-TBK1 complex that controls cytosolic DNA-stimulated innate immune signaling. Citation Format: Xiaojun Tan, Conggang Zhang, Zhijian J. Chen. Lipid control of DNA-stimulated innate immunity [abstract]. In: Proceedings of the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; Sept 30-Oct 3, 2018; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2019;7(2 Suppl):Abstract nr A116.
STING an essential trigger of DNA-mediated innate immune signaling. (P1258)

Glen Barber

DOI: https://doi.org/10.4049/jimmunol.190.supp.116.7

2013-05-01

The Journal of Immunology

Abstract:Abstract Cellular innate immune sensor pathways are essential for identifying invading pathogens and for initiating host defense responses. However, how cells recognize DNA based microbes and trigger innate immune gene activation remains to be fully resolved. Here, we demonstrate that STING, an endoplasmic reticulum associated transmembrane protein, acts as a receptor for cytosolic pathogen associated DNA. This event invoked STING trafficking from the ER through autophagy-related endosomes to promote the activation of interferon regulatory factors IRF- 3, 7 and NF-κB, which triggered the production of host defense genes. STING, predominantly found in endothelial cells, macrophages and dendritic cells, was found to be essential for protecting mice against lethal HSV-1 infection through production of type I interferon. However, while STING was found to be essential for host defense, chronic activation of STING was observed to be responsible for inflammatory disease in two murine model systems. For example, DNaseII-/- and Trex1-/- mice die prematurely due to self-DNA manifested cytokine production. Lethality was prevented in both models through loss of STING since cytosolic self-DNA failed to robustly trigger cytokine production through STING signaling pathways. Our data suggests that STING senses aberrant cytosolic DNA species and is responsible for initiating innate immune gene activation, though may play a key role in inflammation and autoimmune disease manifested through self-DNA.

immunology
Targeting STING oligomerization with small-molecule inhibitors

Fiachra Humphries,Liraz Shmuel-Galia,Zhaozhao Jiang,Jeffrey Y Zhou,Leonard Barasa,Santanu Mondal,Ruth Wilson,Nadia Sultana,Scott A Shaffer,Sze-Ling Ng,G Scott Pesiridis,Paul R Thompson,Katherine A Fitzgerald,Jeffrey Y. Zhou,Scott A. Shaffer,G. Scott Pesiridis,Paul R. Thompson,Katherine A. Fitzgerald

DOI: https://doi.org/10.1073/pnas.2305420120

2023-08-09

Abstract:Stimulator of interferon genes (STING) is an essential adaptor protein required for the inflammatory response to cytosolic DNA. dsDNA activates cGAS to generate cGAMP, which binds and activates STING triggering a conformational change, oligomerization, and the IRF3- and NFκB-dependent transcription of type I Interferons (IFNs) and inflammatory cytokines, as well as the activation of autophagy. Aberrant activation of STING is now linked to a growing number of both rare as well as common chronic inflammatory diseases. Here, we identify and characterize a potent small-molecule inhibitor of STING. This compound, BB-Cl-amidine inhibits STING signaling and production of type I IFNs, IFN-stimulated genes (ISGs) and NFκB-dependent cytokines, but not other pattern recognition receptors. In vivo, BB-Cl-amidine alleviated pathology resulting from accrual of cytosolic DNA in Trex-1 mutant mice. Mechanistically BB-Cl-amidine inhibited STING oligomerization through modification of Cys 148 . Collectively, our work uncovers an approach to inhibit STING activation and highlights the potential of this strategy for the treatment of STING-driven inflammatory diseases.
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

Liufu Deng,Hua Liang,Meng Xu,Xuanming Yang,Byron Burnette,Ainhoa Arina,Xiao-Dong Li,Helena Mauceri,Michael Beckett,Thomas Darga,Xiaona Huang,Thomas F. Gajewski,Zhijian J. Chen,Yang-Xin Fu,Ralph R. Weichselbaum

DOI: https://doi.org/10.1016/j.immuni.2014.10.019

IF: 32.4

2014-01-01

Immunity

Abstract:Ionizing radiation-mediated tumor regression depends on type I interferon (IFN) and the adaptive immune response, but several pathways control I IFN induction. Here, we demonstrate that adaptor protein STING, but not MyD88, is required for type I IFN-dependent antitumor effects of radiation. In dendritic cells (DCs), STING was required for IFN-beta induction in response to irradiated-tumor cells. The cytosolic DNA sensor cyclic GMP-AMP (cGAMP) synthase (cGAS) mediated sensing of irradiated-tumor cells in DCs. Moreover, STING was essential for radiation-induced adaptive immune responses, which relied on type I IFN signaling on DCs. Exogenous IFN-beta treatment rescued the cross-priming by cGAS or STING-deficient DCs. Accordingly, activation of STING by a second messenger cGAMP administration enhanced antitumor immunity induced by radiation. Thus radiation-mediated antitumor immunity in immunogenic tumors requires a functional cytosolic DNA-sensing pathway and suggests that cGAMP treatment might provide a new strategy to improve radiotherapy.

Mechanism by which glucose stimulates the passive absorption of small solutes by the human jejunum in vivo.

Progress in innate immunity signaling molecule STING

A Novel Transcript Isoform of STING That Sequesters Cgamp and Dominantly Inhibits Innate Nucleic Acid Sensing

STAM transports STING oligomers into extracellular vesicles, down‐regulating the innate immune response

2024 Lasker Award Recipient Zhijian Chen elucidates how DNA stimulates immunity

Regulating STING in health and disease

Viral DNA Binding to NLRC3, an Inhibitory Nucleic Acid Sensor, Unleashes STING, a Cyclic Dinucleotide Receptor That Activates Type I Interferon.

STING-mediated DNA sensing in cancer immunotherapy

Advances in the Prerequisite and Consequence of STING Downstream Signalosomes

Cgas-Sting: the Novel Mechanism of Cytosolic DNA Sensing Pathways

Engineering the Immune Adaptor Protein STING as a Biologic

STING-dependent translation inhibition restricts RNA virus replication

STING Negatively Regulates Double-Stranded DNA-Activated JAK1-STAT1 Signaling via SHP-1/2 in B Cells.

DNA sensing via STING regulates autoimmunity and tumor immunity. (IRM5P.648)

Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy

An updated patent review of stimulator of interferon genes agonists (2021 – present)

The STING Phase-Separator Suppresses Innate Immune Signalling.

Abstract A116: Lipid Control of DNA-stimulated Innate Immunity

STING an essential trigger of DNA-mediated innate immune signaling. (P1258)

Targeting STING oligomerization with small-molecule inhibitors

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.